12-Month results of the standardised combination therapy for diabetic macular oedema: Intravitreal bevacizumab and navigated retinal photocoagulation

British Journal of Ophthalmology

Volumn 98, Issue 8, 2014, Pages 1036-1041

  Barteselli, Giulio ^a,b   Kozak, Igor ^a,c   El Emam, Sharif ^a,d   Chhablani, Jay ^a,e   Cortes, Marco A ^f   Freeman, William R ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c KING KHALED EYE SPECIALIST HOSPITAL   (Saudi Arabia)

^d TANTA UNIVERSITY   (Egypt)

^e L V PRASAD EYE INSTITUTE   (India)

^f ISEO Instituto de Sub Especialidades Oftalmologicas   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ARTICLE; CENTRAL RETINAL THICKNESS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DRUG EFFICACY; FEMALE; HUMAN; LASER COAGULATION; MALE; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; RETREATMENT; RETROSPECTIVE STUDY; STANDARDIZATION; TREATMENT RESPONSE; VERY ELDERLY; VISUAL ACUITY;

MACULA; RETINA; TREATMENT LASERS;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; COMBINED MODALITY THERAPY; DIABETIC RETINOPATHY; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; PILOT PROJECTS; RETROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 84905106647     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-304488     Document Type: Article

References (22)

1. Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, et al. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology 2007;114:743-50. (Pubitemid 46483714)
2. Arevalo JF, Sanchez JG, Fromow-Guerra J, et al. Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up. Graefes Arch Clin Exp Ophthalmol 2009;247:735-43.
3. Diabetic Retinopathy Clinical Research N, Elman MJ, Aiello LP, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117:1064-77, e35.
4. Do DV, Nguyen QD, Boyer D, et al. One-year outcomes of the DA VINCI Study of VEGF Trap-Eye in eyes with diabetic macular edema. Ophthalmology 2012;119:1658-65.
5. Elman MJ, Bressler NM, Qin H, et al. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2011;118:609-14.
6. Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011;118:615-25.
7. Nguyen QD, Shah SM, Heier JS, et al. Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study. Ophthalmology 2009;116:2175-81, e1.
8. Nguyen QD, Shah SM, Khwaja AA, et al. Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology 2010;117:2146-51.
9. Soheilian M, Ramezani A, Obudi A, et al. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema. Ophthalmology 2009;116:1142-50.
10. Arevalo JF, Garcia-Amaris RA. Intravitreal bevacizumab for diabetic retinopathy. Curr Diabetes Rev 2009;5:39-46.
11. Arevalo JF, Maia M, Garcia-Amaris RA, et al. Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results. Ophthalmology 2009;116:1481-7, 7 e1.
12. Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 2012;119:789-801.
13. Kozak I, Oster SF, Cortes MA, et al. Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagulator NAVILAS. Ophthalmology 2011;118:1119-24.
14. Lee SN, Chhablani J, Chan CK, et al. Characterization of microaneurysm closure after focal laser photocoagulation in diabetic macular edema. Am J Ophthalmol 2013;155:905-12.
15. Chhablani J, Kozak I, Barteselli G, et al. A novel navigated laser system brings new efficacy to the treatment of retinovascular disorders. Oman J Ophthalmol 2013;6:18-22.
16. Neubauer AS, Langer J, Liegl R, et al. Navigated macular laser decreases retreatment rate for diabetic macular edema: a comparison with conventional macular laser. Clin Ophthalmol 2013;7:121-8.
17. Giani A, Cigada M, Choudhry N, et al. Reproducibility of retinal thickness measurements on normal and pathologic eyes by different optical coherence tomography instruments. Am J Ophthalmol 2010;150:815-24.
18. Kozak I, Kim JS, Oster SF, et al. Focal navigated laser photocoagulation in retinovascular disease: clinical results in initial case series. Retina 2012;32:930-5.
19. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1987;94:761-74.
20. Bloch SB, la Cour M, Sander B, et al. Predictors of 1-year visual outcome in neovascular age-related macular degeneration following intravitreal ranibizumab treatment. Acta Ophthalmol 2013;91:42-7.
21. Chhablani J, Kim JS, Freeman WR, et al. Predictors of visual outcome in eyes with choroidal neovascularization secondary to age related macular degeneration treated with intravitreal bevacizumab monotherapy. Int J Ophthalmol 2013;6:62-6.
22. El-Emam S, Chhablani J, Barteselli G, et al. Correlation of spectral domain optical coherence tomography characteristics with visual acuity in eyes with subfoveal scarring after treatment for wet age-related macular degeneration. Retina 2013;33:1249-57.